Akhil Kumar Thapan
About Akhil Kumar Thapan
Data last updated:
Akhil Kumar Thapan is a Director at Dayton Pharmaceuticals Private Limited (since 2015). The company operates in Trading. Dayton Pharmaceuticals Private Limited reported revenue of ₹40.8 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dayton Pharmaceuticals Private Limited U52100UP2015PTC070115 | Director | 15 Apr 2015 | 2015 | ₹40.8 Lakh (FY 2024) | Active |
Board colleagues of Akhil Kumar Thapan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anushi Agarwal | 08700805 | Dayton Pharmaceuticals Private Limited | Director |
| Nitin Gupta | 09750914 | Dayton Pharmaceuticals Private Limited | Director |
| Sarika Thapan | 07132258 | Dayton Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akhil Kumar Thapan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akhil Kumar Thapan
Akhil Kumar Thapan currently holds 1 directorship: Dayton Pharmaceuticals Private Limited (Director, since 15 Apr 2015, revenue ₹40.8 Lakh (FY 2024)).
Akhil Kumar Thapan was first appointed on 15 Apr 2015 as Director at Dayton Pharmaceuticals Private Limited.
The current boards of Akhil Kumar Thapan's companies include Anushi Agarwal (Dayton Pharmaceuticals Private Limited), Nitin Gupta (Dayton Pharmaceuticals Private Limited), Sarika Thapan (Dayton Pharmaceuticals Private Limited).